//
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life
The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Modifiable lifestyle factors and heart failure: A Mendelian randomization study
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial